Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Objective: Sepsis is the leading cause of death in critically ill patients. The gastrointestinal tract has long been thought to play an important role in the pathophysiology of sepsis. Antibiotic therapy can reduce a patient’s commensal bacterial population and raise their risk of developing subsequent illnesses, where gut microbiota dysbiosis may be a key factor. Methods: In this study, we analyzed the 16S rRNA of fecal samples from both healthy people and patients with sepsis to determine if alterations in gut bacteria are associated with sepsis. Then, we developed a mouse model of sepsis using cecal ligation and puncture (CLP) in order to examine the effects of fecal microbiota transplantation (FMT) and short-chain fatty acids (SCFAs) on survival rate, systemic inflammatory response, gut microbiota, and mucosal barrier function. Results: Sepsis patients’ gut microbiota composition significantly differed from that of healthy people. At the phylum level, the amount of Proteobacteria in the intestinal flora of sepsis patients was much larger than that of the control group, whereas the number of Firmicutes was significantly lower. Mice with gut microbiota disorders (ANC group) were found to have an elevated risk of death, inflammation, and organ failure as compared to CLP mice. However, all of these could be reversed by FMT and SCFAs. FMT and SCFAs could regulate the abundance of bacteria such as Firmicutes, Proteobacteria, Escherichia Shigella, and Lactobacillus, restoring them to levels comparable to those of healthy mice. In addition, they increased the expression of the Occludin protein in the colon of mice with sepsis, downregulated the expression of the NLRP3 and GSDMD-N proteins, and reduced the release of the inflammatory factors IL-1β and IL-18 to inhibit cell pyroptosis, ultimately playing a protective role in sepsis. Disccusion: FMT and SCFAs provide a microbe-related survival benefit in a mouse model of sepsis, suggesting that they may be a viable treatment for sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“broad-spectrum antibiotics – the strongest iatrogenic driver”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Lou et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Gut microbiota plays a key role in sepsis pathogenesis, but evidence is often mixed.”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Lou et al., 2022
The cited source says what the claim attributes to it.
In the citing paper
“In animal sepsis models, SCFAs reduce mortality (Lou et al., 2022).”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Lou et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Seymour, C. W., Liu, V. X., Iwashyna, T. J., Brunkhorst, F. M., Rea, T. D., Scherag, A., Rubenfeld, G., Kahn, J. M., Shankar-Hari, M., Singer, M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0288 · Cited by 3,939
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., Kayser, B. D., Levenez, F., Chilloux, J., Hoyles, L., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308778 · Cited by 1,931
Liver injury in COVID-19: management and challenges
Zhang, C., Shi, L., & Wang, F.-S. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30057-1 · Cited by 1,906
Self-citationMechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281 · cited 1×
“In patients at risk of dysbiosis, a tailored microbiota therapy that involves the replacement of particular commensal or short-chain fatty acids-producing bacteria may reduce their susceptibility to sepsis (48, 49).”
BackgroundWiklund, S., Johansson, E., Sjöström, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., Gottfries, J., Moritz, T., & Trygg, J. (2008) · Analytical Chemistry · doi:10.1021/ac0713510 · Cited by 1,233
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207 · cited 1×
“Following the guideline, each person should donate 30 g of feces, which should then be diluted with 3-5 times as much sterile saline (for example, 30 g of feces diluted with 150 ml of normal saline) (29).”
MethodSARS-CoV-2 and viral sepsis: observations and hypotheses
Li, H., Liu, L., Zhang, D., Xu, J., Dai, H., Tang, N., Su, X., & Cao, B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30920-x · Cited by 1,178
Interaction between drugs and the gut microbiome
Weersma, R. K., Zhernakova, A., & Fu, J. (2020) · Gut · doi:10.1136/gutjnl-2019-320204 · Cited by 961
Schneeberger, M., Everard, A., Gómez-Valadés, A. G., Matamoros, S., Ramírez, S., Delzenne, N. M., Gomis, R., Claret, M., & Cani, P. D. (2015) · Scientific Reports · doi:10.1038/srep16643 · Cited by 798
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Wang, Y., Wiesnoski, D. H., Helmink, B. A., Gopalakrishnan, V., Choi, K., DuPont, H. L., Jiang, Z.-D., Abu-Sbeih, H., Sanchez, C. A., Chang, C.-C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0238-9 · Cited by 740 · cited 1×
“Recent clinical trials have demonstrated that FMT is effective in eradicating colonized drug-resistant bacteria in patients with hematological malignancies and restoring treatment for colitis (41, 42).”
BackgroundWeiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Carbohydrate-active enzymes (CAZymes) in the gut microbiome
Wardman, J. F., Bains, R. K., Rahfeld, P., & Withers, S. G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00712-1 · Cited by 597 · cited 1×
“The gut microbiota has been shown to play an important role in both health and illness (8).”
BackgroundReunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., de Vos, W. M., & Satokari, R. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.04050-14 · Cited by 553
Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions
Aglietti, R. A., & Dueber, E. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.003 · Cited by 407
Gut firmicutes: Relationship with dietary fiber and role in host homeostasis
Sun, Y., Zhang, S., Nie, Q., He, H., Tan, H., Geng, F., Ji, H., Hu, J., & Nie, S. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2098249 · Cited by 400
The role of the gut microbiota in sepsis
Haak, B. W., & Wiersinga, W. J. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30119-4 · Cited by 367
Signaling pathways and intervention therapies in sepsis
Zhang, Y.-Y., & Ning, B.-T. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00816-9 · Cited by 349
The gut microbiome’s role in the development, maintenance, and outcomes of sepsis
Adelman, M. W., Woodworth, M. H., Langelier, C., Busch, L. M., Kempker, J. A., Kraft, C. S., & Martin, G. S. (2020) · Critical Care · doi:10.1186/s13054-020-02989-1 · Cited by 342
Mocanu, V., Zhang, Z., Deehan, E. C., Kao, D. H., Hotte, N., Karmali, S., Birch, D. W., Samarasinghe, K. K., Walter, J., & Madsen, K. L. (2021) · Nature Medicine · doi:10.1038/s41591-021-01399-2 · Cited by 328
Yang, X., Cheng, X., Tang, Y., Qiu, X., Wang, Y., Kang, H., Wu, J., Wang, Z., Liu, Y., Chen, F., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.11.005 · Cited by 325
Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn
Xu, K., Gao, X., Xia, G., Chen, M., Zeng, N., Wang, S., You, C., Tian, X., Di, H., Tang, W., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323263 · Cited by 308
Antibiotics promote inflammation through the translocation of native commensal colonic bacteria
Knoop, K. A., McDonald, K. G., Kulkarni, D. H., & Newberry, R. D. (2016) · Gut · doi:10.1136/gutjnl-2014-309059 · Cited by 274
Bilinski, J., Grzesiowski, P., Sorensen, N., Madry, K., Muszynski, J., Robak, K., Wroblewska, M., Dzieciatkowski, T., Dulny, G., Dwilewicz-Trojaczek, J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix252 · Cited by 266
Sorbara, M. T., Dubin, K., Littmann, E. R., Moody, T. U., Fontana, E., Seok, R., Leiner, I. M., Taur, Y., Peled, J. U., van den Brink, M. R. M., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181639 · Cited by 259 · cited 1×
“Additionally, gut Enterobacteriaceae overgrowth increases sepsis and death risk (59).”
BackgroundGut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice
Gong, S., Lan, T., Zeng, L., Luo, H., Yang, X., Li, N., Chen, X., Liu, Z., Li, R., Win, S., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.024 · Cited by 255
Shimizu, K., Yamada, T., Ogura, H., Mohri, T., Kiguchi, T., Fujimi, S., Asahara, T., Yamada, T., Ojima, M., Ikeda, M., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2167-x · Cited by 234
Zhang, F., Wan, Y., Zuo, T., Yeoh, Y. K., Liu, Q., Zhang, L., Zhan, H., Lu, W., Xu, W., Lui, G. C. Y., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.013 · Cited by 234
The Role and Mechanism of Pyroptosis and Potential Therapeutic Targets in Sepsis: A Review
Zheng, X., Chen, W., Gong, F., Chen, Y., & Chen, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.711939 · Cited by 220
Neutrophil pyroptosis: new perspectives on sepsis
Liu, L., & Sun, B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03060-1 · Cited by 195
Wu, N., Dai, J., Guo, M., Li, J., Zhou, X., Li, F., Gao, Y., Qu, H., Lu, H., Jin, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1902754 · Cited by 178
Metformin attenuated sepsis-related liver injury by modulating gut microbiota
Liang, H., Song, H., Zhang, X., Song, G., Wang, Y., Ding, X., Duan, X., Li, L., Sun, T., & Kan, Q. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2045876 · Cited by 176
Fecal Microbiota Transplantation
Gupta, A., & Khanna, S. (2017) · JAMA · doi:10.1001/jama.2017.6466 · Cited by 169
Dual role of microbiota-derived short-chain fatty acids on host and pathogen
Mirzaei, R., Dehkhodaie, E., Bouzari, B., Rahimi, M., Gholestani, A., Hosseini-Fard, S. R., Keyvani, H., Teimoori, A., & Karampoor, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112352 · Cited by 163
Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli
Shawki, A., & McCole, D. F. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.10.004 · Cited by 153
Vitetta, L., Vitetta, G., & Hall, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02240 · Cited by 152
Kim, S. M., DeFazio, J. R., Hyoju, S. K., Sangani, K., Keskey, R., Krezalek, M. A., Khodarev, N. N., Sangwan, N., Christley, S., Harris, K. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15545-w · Cited by 136
Zhang, X., Xu, L., Shen, J., Cao, B., Cheng, T., Zhao, T., Liu, X., & Zhang, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.009 · Cited by 130
Tight junction structure, function, and assessment in the critically ill: a systematic review
Vermette, D., Hu, P., Canarie, M. F., Funaro, M., Glover, J., & Pierce, R. W. (2018) · Intensive Care Medicine Experimental · doi:10.1186/s40635-018-0203-4 · Cited by 128
Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients
Ravi, A., Halstead, F. D., Bamford, A., Casey, A., Thomson, N. M., van Schaik, W., Snelson, C., Goulden, R., Foster-Nyarko, E., Savva, G. M., et al. (2019) · Microbial Genomics · doi:10.1099/mgen.0.000293 · Cited by 125
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2015) · Critical Care · doi:10.1186/s13054-015-0738-7 · Cited by 118
The central and biodynamic role of gut microbiota in critically ill patients
Wozniak, H., Beckmann, T. S., Fröhlich, L., Soccorsi, T., Terrier, C. L., de Watteville, A., Schrenzel, J., & Heidegger, C. (2022) · Critical Care · doi:10.1186/s13054-022-04127-5 · Cited by 114
A crosstalk between gut and brain in sepsis-induced cognitive decline
Giridharan, V. V., Generoso, J. S., Lence, L., Candiotto, G., Streck, E., Petronilho, F., Pillai, A., Sharshar, T., Dal-Pizzol, F., & Barichello, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02472-4 · Cited by 95
(2020) · doi:10.1016/j.gpb.2020.06.011 · Cited by 84
Livanos, A. E., Snider, E. J., Whittier, S., Chong, D. H., Wang, T. C., Abrams, J. A., & Freedberg, D. E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0200322 · Cited by 70
Huang, S.-S., Lin, J.-Y., Chen, W.-S., Liu, M., Cheng, C., Cheng, M., & Wang, C. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.05.030 · Cited by 62
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.299 · Cited by 61
The emerging role of the microbiota in the ICU
Wolff, N. S., Hugenholtz, F., & Wiersinga, W. J. (2018) · Critical Care · doi:10.1186/s13054-018-1999-8 · Cited by 60
Xu, J., Liu, Z., Zhan, W., Jiang, R., Yang, C., Zhan, H., & Xiong, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7946 · Cited by 36
Spanaki, A., Tavladaki, T., Dimitriou, H., Kozlov, A. V., Duvigneau, J. C., Meleti, E., Weidinger, A., Papakonstantinou, E., & Briassoulis, G. C. (2018) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1050 · Cited by 35
Intestinal microbiota and antibiotic-associated acute gastrointestinal injury in sepsis mice
Han, C., Guo, N., Bu, Y., Peng, Y., Li, X., Ma, X., Yang, M., Jia, X., Zhang, J., Liu, X., et al. (2021) · Aging · doi:10.18632/aging.202768 · Cited by 22
Alterations of the Gut Microbiome in Chinese Zhuang Ethnic Patients with Sepsis
Yu, J., Li, H., Zhao, J., Huang, Y., Liu, C., Yang, P., Lu, D., Song, J., & Meng, L. (2022) · Mediators of Inflammation · doi:10.1155/2022/2808249 · Cited by 13
Gupta, S., Zhu, J., McCarty, T. R., Pruce, J. C., Kassam, Z., Kelly, C. R., Fischer, M., & Allegretti, J. R. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15483 · Cited by 9
Chen, Y., Luo, R., Li, J., Wang, S., Ding, J., Zhao, K., Lü, B., & Zhou, W. (2022) · ACS Nano · doi:10.1021/acsnano.2c01759 · Cited by 7
Cited by
The Gut–Kidney Axis in Chronic Kidney Diseases
Tsuji, K., Uchida, N., Nakanoh, H., Fukushima, K., Haraguchi, S., Kitamura, S., & Wada, J. (2024) · Diagnostics · doi:10.3390/diagnostics15010021 · Cited by 161
Karnwal, A., Jassim, A. Y., Mohammed, A. A., Al-Tawaha, A. R., Selvaraj, M., & Malik, T. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1517772 · Cited by 137
Gut microbiota in health and disease: advances and future prospects
Zhang, Y., Wang, H., Sang, Y., Liu, M., Wáng, Q., Yang, H., & Li, X. (2024) · MedComm · doi:10.1002/mco2.70012 · Cited by 80
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy
Piccioni, A., Spagnuolo, F., Candelli, M., Voza, A., Covino, M., Gasbarrini, A., & Franceschi, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206082 · Cited by 63
Gut microbiota: a promising new target in immune tolerance
Almansour, N., Al‐Rashed, F., Choudhry, K., Alqaderi, H. E., Sindhu, S. T. A. K., Al‐Mulla, F., & Ahmad, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1607388 · Cited by 59
Metadata
- Authors
- Lou, X., Xue, J., Shao, R., Yang, Y., Ning, D., Mo, C., Wang, F., & Chen, G.
- Affiliations
- Kunming University of Science and Technology (CN)
- First People's Hospital of Yunnan Province (CN)
- Corresponding author
- Chen, Guobing
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-01-11
- Volume
- 13
- Pages
- 1063543-1063543
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9874322
- OpenAlex
- W4315648768
- Cited by
- 87
- References
- 62
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 19 · 2023: 15
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Keywords
- sepsis, fecal microbiota transplantation, short-chain fatty acids, gut dysbiosis, antibiotic-induced dysbiosis, cecal ligation and puncture, Proteobacteria, Firmicutes, occludin, intestinal barrier function, pyroptosis, NLRP3 inflammasome, gasdermin D, IL-1β, IL-18, sepsis mortality
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Anti-Bacterial Agents, Fatty Acids, Volatile, RNA, Ribosomal, 16S, Sepsis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.